Form EFFECT Karyopharm Therapeutics
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 7, 2024 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeanDNA Names Winners of Its Second Annual APEX Awards, Honoring Supply Chain Excellence Across Six Categories
- TPM Holdings Accelerates Investment in AI and Salesforce CRM for the Built World
- Boehringer Ingelheim registers Phase III trial investigating verducatib in COPD
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share